000 | 01148 a2200337 4500 | ||
---|---|---|---|
005 | 20250514165830.0 | ||
264 | 0 | _c20040625 | |
008 | 200406s 0 0 ger d | ||
022 | _a0020-9554 | ||
024 | 7 |
_a10.1007/s00108-003-1094-2 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aJosting, A | |
245 | 0 | 0 |
_a[Modern pharmacotherapy of Hodgkin disease]. _h[electronic resource] |
260 |
_bDer Internist _cJan 2004 |
||
300 |
_a93-101 p. _bdigital |
||
500 | _aPublication Type: English Abstract; Journal Article; Review | ||
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
650 | 0 | 4 | _aCombined Modality Therapy |
650 | 0 | 4 |
_aHodgkin Disease _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xdrug therapy |
650 | 0 | 4 | _aNeoplasm Staging |
650 | 0 | 4 | _aRadiotherapy, Adjuvant |
650 | 0 | 4 | _aSurvival Rate |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aBehringer, K | |
700 | 1 | _aEngert, A | |
700 | 1 | _aDiehl, V | |
773 | 0 |
_tDer Internist _gvol. 45 _gno. 1 _gp. 93-101 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00108-003-1094-2 _zAvailable from publisher's website |
999 |
_c14460918 _d14460918 |